|
|
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1004-1012.
Prepublished online as a Blood First Edition Paper on October 17, 2007; DOI 10.1182/blood-2007-09-110874.
Previous Article | Next Article 
Submitted September 7, 2007
Accepted October 5, 2007
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen, Teresa G Cachero, Aubry Tardivel, Karine Ingold, Laure Willen, Max Dobles, Martin L Scott, Aris Maquelin, Elodie Belnoue, Claire-Anne Siegrist, Stephane Chevrier, Hans Acha-Orbea, Helen Leung, Fabienne Mackay, Jurg Tschopp, and Pascal Schneider*
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
BiogenIdec, Cambridge, MA, United States
Department of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland
Garvan Institute of Medical Research, Darlinghurst, Australia
* Corresponding author; email: pascal.schneider{at}unil.ch.
The cytokine BAFF binds to the receptors TACI, BCMA and BAFF-R on B cells, whereas APRIL binds to TACI and BCMA only. The signaling properties of soluble trimeric BAFF (BAFF 3-mer) were compared to those of higher order BAFF oligomers. All forms of BAFF bound BAFF-R and TACI,and elicited BAFF-R-dependent signals in primary B cells. In contrast, signaling through TACI in mature B cells or plasmablasts was only achieved by higher order BAFF andAPRIL oligomers, all of which were also potent activators of a multimerizationdependent reporter signaling pathway. These results indicate that although BAFF-R andTACI can provide B cells with similar signals, only BAFF-R, but not TACI, can respond to soluble BAFF 3-mer, which is the main form of BAFF found in circulation. BAFF 60-mer, an efficient TACI agonist, was also detected in plasma of BAFF transgenic and nontransgenic mice and was greater than 100-fold more active than BAFF 3-mer for the activation of multimerization-dependent signals. TACI supported survival of activated B cells and plasmablasts in vitro, providing a rational basis to explain the immunoglobulindeficiency reported in TACI-deficient individuals.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Different partners in different places?
- Michael P. Cancro
Blood 2008 111: 975.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Lee, I. Rauter, L. Garibyan, E. Ozcan, T. Sannikova, S. R. Dillon, A. C. Cruz, R. M. Siegel, R. Bram, H. Jabara, et al.
The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function
Blood,
September 10, 2009;
114(11):
2254 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wyzgol, N. Muller, A. Fick, S. Munkel, G. U. Grigoleit, K. Pfizenmaier, and H. Wajant
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
J. Immunol.,
August 1, 2009;
183(3):
1851 - 1861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tertilt, J. Joh, A. Krause, P. Chou, K. Schneeweiss, R. G. Crystal, and S. Worgall
Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa
Infect. Immun.,
July 1, 2009;
77(7):
3044 - 3055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Salzer, C. Bacchelli, S. Buckridge, Q. Pan-Hammarstrom, S. Jennings, V. Lougaris, A. Bergbreiter, T. Hagena, J. Birmelin, A. Plebani, et al.
Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes
Blood,
February 26, 2009;
113(9):
1967 - 1976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mohr, K. Serre, R. A. Manz, A. F. Cunningham, M. Khan, D. L. Hardie, R. Bird, and I. C. M. MacLennan
Dendritic Cells and Monocyte/Macrophages That Create the IL-6/APRIL-Rich Lymph Node Microenvironments Where Plasmablasts Mature
J. Immunol.,
February 15, 2009;
182(4):
2113 - 2123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|